Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
Nicola J. Hewitt(Yahoo (United Kingdom)), María José Gómez Lechón(Instituto de Investigación Sanitaria La Fe), J. Brian Houston(University of Manchester), David Hallifax(University of Manchester), Hayley S. Brown(University of Manchester), Patrick Maurel(Université de Montpellier), J. Gerry Kenna(AstraZeneca (United Kingdom)), Lena Gustavsson(AstraZeneca (Sweden)), Christina Lohmann(AstraZeneca (Sweden)), Christian Skonberg, André Guillouzo(Inserm), Gregor Tuschl(Merck (Germany)), Albert P. Li, Edward L. LeCluyse, Geny M. M. Groothuis(University of Groningen), Jan G. Hengstler(Leipzig University)
Cited by 729
Abstract
This review brings you up-to-date with the hepatocyte research on: 1) in vitro-in vivo correlations of metabolism and clearance; 2) CYP enzyme induction, regulation, and cross-talk using human hepatocytes and hepatocyte-like cell lines; 3) the function and regulation of hepatic transporters and models used to elucidate their role in drug clearance; 4) mechanisms and examples of idiosyncratic and intrinsic hepatotoxicity; and 5) alternative cell systems to primary human hepatocytes. We also report pharmaceutical perspectives of these topics and compare methods and interpretations for the drug development process.
Related Papers
No related papers found
Powered by citation graph analysis